Ledger.Open graph →
SEC Form D · filed June 11, 2019

DermBiont, Inc

Offering
$8.8M
Sold
$8.8M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
BOSTON, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (4)

Karl R. Beutner · Boston, MAExec · DirectorNichola R. Eliovits · Boston, MAExec · DirectorKarl R. Beutner · Boston, MAExec · DirectorNichola R. Eliovits · Boston, MAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗